Last reviewed · How we verify
NCT07228000
Bundled Cancer Screening and Genetic Services Navigation
NA trial testing Breast cancer screening navigation in Breast Cancer Screening in 820 participants. Not yet recruiting.
28 February 2029
Quick facts
| Lead sponsor | Georgetown University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 820 |
| Start date | 1 May 2026 |
| Primary completion | 28 February 2029 |
| Estimated completion | 31 May 2029 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Breast cancer screening navigation
- Multicancer screening navigation
- Usual care genetics referral
- Pretest education + usual care genetics referral
Conditions studied
- Breast Cancer Screening — all drugs for Breast Cancer Screening →
- Colon Cancer Screening — all drugs for Colon Cancer Screening →
- Genetics Predisposition — all drugs for Genetics Predisposition →
Sponsor
Georgetown University
Who can join
Adults 45 to 74, female only, with Breast Cancer Screening or Colon Cancer Screening. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to test bundled familial cancer risk assessment + multicancer (colorectal + breast) vs. single (breast) cancer navigation, using a wait list control for colorectal cancer screening referral and navigation. Among those eligible, this study will test usual care referral to genetic services vs. pretest education + usual care referral. The study also will assess how bundled multicancer navigation works and for whom it is most effective through a multisite, mixed-methods patient- and organization-level process evaluation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07228000
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer Screening
Currently open trials in the same condition.
- NCT07067788 — B.Brilliant Revelation Comparision Study · recruiting
- NCT06934239 — A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detec · Phase 4 · recruiting
- NCT07075679 — Screening Mammography: Single Reading by One Radiologist With AI vs. Double Reading by Two Radiologists (AI-BCSQ) · NA · recruiting
- NCT06876610 — Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer · recruiting
- NCT07411443 — AI-Enhanced Imaging in Population Breast Cancer Screening · NA · recruiting
Other Georgetown University trials
Trials by the same sponsor.
- NCT07128927 — Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors · NA · recruiting
- NCT06046287 — Daratumumab for Polyneuropathy Associated With MGUS · Phase 2 · withdrawn
- NCT06980103 — Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyro · NA · recruiting
- NCT07105358 — Visual Plasticity Following Brain Lesions · NA · recruiting
- NCT07418905 — Technology-supported Motor Rehabilitation for People With Rett Syndrome · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07228000 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Georgetown University
- Last refreshed: 9 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07228000.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing